Summary
A new SaaS platform allows pharmaceutical companies to track and trace products globally, combating counterfeits and ensuring regulatory compliance. It enhances supply chain visibility and product integrity. The “Pharmaceutical Track-and-Trace SaaS Platform” directly combats counterfeit medicines, addresses complex regulatory compliance, and unifies fragmented data across stakeholders in the supply chain. This platform enables pharmaceutical companies to track and trace products from production to final sale, ensuring adherence to global standards like US DSCSA, EU FMD, and India’s iVed. It significantly enhances product integrity, reduces counterfeit risks, and improves overall supply chain visibility, having recently secured $2.25 million in seed funding and serving various industries beyond pharma.
Problem
Counterfeit medicines infiltrating the supply chain, complex regulatory compliance, and fragmented data across stakeholders.
Impact
Secured $2.25 million in seed funding; serves industries such as life sciences, defense, fine chemicals, and luxury goods
Partners
Microsoft Azure , Endiya Partners , Audree Infotech , Angel Investors , India’s iVEDA.